Authors: RUTKOWSKI B SZOLKIEWICZ M MANITIUS J MYSLIWSKA J BRYL E MYSLIWSKI A

Citation: B. Rutkowski et al., THE INFLUENCE OF ERYTHROPOIETIN ON CYTOKINES IN HEMODIALYSIS-PATIENTS, Nephrology, 3(4), 1997, pp. 323-327

Authors: MYSLIWSKA J BRYL E SZOLKIEWICZ M MANITIUS J MYSLIWSKI A RUTKOWSKI B

Citation: J. Mysliwska et al., LOW-DOSES OF RECOMBINANT-HUMAN-ERYTHROPOIETIN RAISE SERUM INTERLEUKIN-2 LEVELS IN HEMODIALYSIS-PATIENTS, JN. Journal of nephrology, 9(1), 1996, pp. 30-34

Authors: SZOLKIEWICZ M ZDROJEWSKI Z SULIMAGILLOW A RUTKOWSKI B

Citation: M. Szolkiewicz et al., CAN HYPERCALCEMIA BE AVOIDED DURING ORAL CALCITRIOL PULSE THERAPY OF SECONDARY HYPERPARATHYROIDISM IN HEMODIALYSIS-PATIENTS, Nephrology, dialysis, transplantation, 10(9), 1995, pp. 1781-1782

Authors: MANITIUS J SZOLKIEWICZ M MYSLIWSKA J ZORENA K MYSLIWSKI A JAKUBOWSKI Z LYSIAKSZYDLOWSKA W RUTKOWSKI B

Citation: J. Manitius et al., INFLUENCE OF NONHEMATOLOGICAL DOSES OF ERYTHROPOIETIN ON LIPID-CARBOHYDRATE METABOLISM AND LIFE QUALITY IN HEMODIALYSIS-PATIENTS, Nephron, 69(3), 1995, pp. 363-364